Variant report
Variant | rs461338 |
---|---|
Chromosome Location | chr6:33218180-33218181 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:33215600-33218200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr6:33216200-33218200 | Flanking Active TSS | NH-A | brain |
3 | chr6:33216600-33218600 | Enhancers | Sigmoid Colon | Sigmoid Colon |
4 | chr6:33217000-33218200 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
5 | chr6:33217400-33218200 | Flanking Active TSS | Primary hematopoietic stem cells | blood |
6 | chr6:33217400-33218200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr6:33217400-33218200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr6:33217400-33218200 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr6:33217400-33218200 | Flanking Active TSS | Duodenum Mucosa | Duodenum |
10 | chr6:33217400-33218200 | Flanking Active TSS | Skeletal Muscle Male | skeletal muscle |
11 | chr6:33217400-33218200 | Flanking Active TSS | Dnd41 | blood |
12 | chr6:33217400-33218200 | Flanking Active TSS | NHLF | lung |
13 | chr6:33217400-33218200 | Flanking Active TSS | Osteobl | bone |
14 | chr6:33217400-33218400 | Flanking Active TSS | Primary T helper cells PMA-I stimulated | -- |
15 | chr6:33217400-33218400 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
16 | chr6:33217400-33218400 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
17 | chr6:33217400-33218400 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
18 | chr6:33217400-33218600 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
19 | chr6:33217400-33218600 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
20 | chr6:33217400-33218600 | Flanking Active TSS | NHDF-Ad | bronchial |
21 | chr6:33217400-33234200 | Weak transcription | Small Intestine | intestine |
22 | chr6:33217600-33218200 | Flanking Active TSS | Brain Hippocampus Middle | brain |
23 | chr6:33217600-33218200 | Flanking Active TSS | GM12878-XiMat | blood |
24 | chr6:33217600-33218400 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
25 | chr6:33217600-33218400 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
26 | chr6:33217600-33218800 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
27 | chr6:33217600-33218800 | Flanking Active TSS | Hela-S3 | cervix |
28 | chr6:33217600-33219000 | Flanking Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
29 | chr6:33217800-33218200 | Enhancers | Primary monocytes fromperipheralblood | blood |
30 | chr6:33217800-33218200 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
31 | chr6:33217800-33218200 | Enhancers | Fetal Brain Male | brain |
32 | chr6:33217800-33218200 | Flanking Active TSS | HepG2 | liver |
33 | chr6:33217800-33218400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
34 | chr6:33217800-33218400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
35 | chr6:33217800-33218400 | Transcr. at gene 5' and 3' | Primary hematopoietic stem cells short term culture | blood |
36 | chr6:33217800-33218400 | Enhancers | Fetal Heart | heart |
37 | chr6:33217800-33218400 | Enhancers | Pancreas | Pancrea |
38 | chr6:33217800-33218600 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
39 | chr6:33217800-33218600 | Enhancers | Placenta Amnion | Placenta Amnion |
40 | chr6:33217800-33231200 | Weak transcription | H9 Cell Line | embryonic stem cell |
41 | chr6:33217800-33231200 | Weak transcription | Aorta | Aorta |
42 | chr6:33217800-33231400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
43 | chr6:33218000-33218200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
44 | chr6:33218000-33218200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
45 | chr6:33218000-33218200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
46 | chr6:33218000-33218200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
47 | chr6:33218000-33218200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
48 | chr6:33218000-33218200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
49 | chr6:33218000-33218200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
50 | chr6:33218000-33218200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |